ImageneBio, Inc.
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
IMA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45175G1085
- LEI:
- Country:
- United States of America
- Address:
- 12526 HIGH BLUFF DRIVE, 92130 SAN DIEGO
- Website:
- https://inmagenebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ImageneBio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering a new generation of therapies for immunological and inflammatory (I&I) diseases. The company develops differentiated, best-in-class treatments by leveraging its proprietary QuadraTek® platform alongside external innovation. Its pipeline is engineered to address a broad spectrum of I&I indications with an emphasis on optimizing safety, efficacy, and convenience to provide better outcomes for patients. ImageneBio was formed in July 2025 following the merger of Inmagene Biopharmaceuticals and Ikena Oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ImageneBio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ImageneBio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ImageneBio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
